Entrada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 08, 2023 at 07:14 am EDT
Entrada Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 25.93 million compared to USD 23.18 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 0.74 a year ago.
For the six months, net loss was USD 32.6 million compared to USD 44.85 million a year ago. Basic loss per share from continuing operations was USD 0.99 compared to USD 1.43 a year ago.